Materias dentro de su búsqueda.
Mostrando 22,221 - 22,240 Resultados de 22,268 Para Buscar '"director"', tiempo de consulta: 0.25s Limitar resultados
  1. 22221
    “…Methods: Nine in-depth interviews were performed: seven with district managers and two with the chief directors of the metropolitan and rural DHS. Interviews were recorded, transcribed and analysed using the ATLAS-ti and the framework method. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Assessment of the impact of family physicians in the district health system of the Western Cape, South Africa
  2. 22222
    por Abiola, Solomon, Bush, Kristen
    Publicado 2018
    “…We then developed network topologies for each university network, and explore the evolution of individuals in these networks, and the effects of faculty development—as an example in the University of Rochester network, we singled out the directors of the CTSA program there to understand their level of centrality and overall impact on network development, with key observations being that early publications across varying domains lead to stronger network performance. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    2527: Citation network towards faculty development inside and outside of CTSAs
  3. 22223
    “…Hungria:  Takeda: Honoraria; Amgen, BMS, Celgene, Janssen: Honoraria, Membership on an entity's Board of Directors or advisory committees, Other: Support for attending meetings/travel ; Abbvie: Honoraria; Sanofi: Honoraria, Other: Support for attending meetings/travel .…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    COVID-19 in Multiple Myeloma Patients: Frequencies and Risk Factors for Hospitalization, Ventilatory Support, Intensive Care Admission and Mortality -Cooperative Registry from Grupo Brasileiro De Mieloma Multiplo (GBRAM)
  4. 22224
    “…Vardhana:  Immunai: Membership on an entity's Board of Directors or advisory committees. Perales:  Equilium: Honoraria; Cidara: Honoraria; Sellas Life Sciences: Honoraria; Miltenyi Biotec: Honoraria, Other; Celgene: Honoraria; MorphoSys: Honoraria; Takeda: Honoraria; Incyte: Honoraria, Other; Karyopharm: Honoraria; Kite/Gilead: Honoraria, Other; Merck: Honoraria; NexImmune: Honoraria; Novartis: Honoraria, Other; Medigene: Honoraria; Omeros: Honoraria; Servier: Honoraria; Bristol-Myers Squibb: Honoraria; Nektar Therapeutics: Honoraria, Other. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Timing and Immune Status after Cellular Therapies Predict Response to COVID-19 Vaccines
  5. 22225
    “…DISCLOSURES: Mosnier:  Hematherix: Membership on an entity's Board of Directors or advisory committees; Coagulant Therapeutics: Research Funding.…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Sars-Cov-2 Infection Promotes Endothelial Dysfunction and Thrombosis in a Mouse Model of COVID-19
  6. 22226
    por His, Mathilde, Viallon, Vivian, Dossus, Laure, Gicquiau, Audrey, Achaintre, David, Scalbert, Augustin, Ferrari, Pietro, Romieu, Isabelle, Onland-Moret, N. Charlotte, Weiderpass, Elisabete, Dahm, Christina C., Overvad, Kim, Olsen, Anja, Tjønneland, Anne, Fournier, Agnès, Rothwell, Joseph A., Severi, Gianluca, Kühn, Tilman, Fortner, Renée T., Boeing, Heiner, Trichopoulou, Antonia, Karakatsani, Anna, Martimianaki, Georgia, Masala, Giovanna, Sieri, Sabina, Tumino, Rosario, Vineis, Paolo, Panico, Salvatore, van Gils, Carla H., Nøst, Therese H., Sandanger, Torkjel M., Skeie, Guri, Quirós, J. Ramón, Agudo, Antonio, Sánchez, Maria-Jose, Amiano, Pilar, Huerta, José María, Ardanaz, Eva, Schmidt, Julie A., Travis, Ruth C., Riboli, Elio, Tsilidis, Konstantinos K., Christakoudi, Sofia, Gunter, Marc J., Rinaldi, Sabina
    Publicado 2019
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Prospective analysis of circulating metabolites and breast cancer in EPIC
  7. 22227
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Graduating Medical Students’ Experiences with Away (In-Person and Virtual) Rotations During COVID-19: Analysis of the Association of American Medical Colleges (AAMC) 2021 Graduation Questionnaire (GQ)
  8. 22228
    “…FUNDING: TB Alliance, UK Department for International Development, Bill & Melinda Gates Foundation, US Agency for International Development, Directorate General for International Cooperation of the Netherlands, Irish Aid, Australia Department of Foreign Affairs and Trade, and the Federal Ministry for Education and Research of Germany.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Bedaquiline, moxifloxacin, pretomanid, and pyrazinamide during the first 8 weeks of treatment of patients with drug-susceptible or drug-resistant pulmonary tuberculosis: a multicentre, open-label, partially randomised, phase 2b trial
  9. 22229
    “…Miguel-Angel Perales, MD, Abbvie (Other Financial or Material Support, Honoraria from Abbvie, Bellicum, Celgene, Bristol-Myers Squibb, Incyte, Merck, Novartis, Nektar Therapeutics, Omeros, and Takeda.)ASTCT (Other Financial or Material Support, Volunteer member of the Board of Directors of American Society for Transplantation and Cellular Therapy (ASTCT), Be The Match (National Marrow Donor Program, NMDP), and the CIBMTR Cellular Immunotherapy Data Resource (CIDR) Committee)Cidara Therapeutics (Advisor or Review Panel member, Other Financial or Material Support, Serve on DSMBs for Cidara Therapeutics, Servier and Medigene, and the scientific advisory boards of MolMed and NexImmune.)Kite/Gilead (Research Grant or Support, Other Financial or Material Support, Received research support for clinical trials from Incyte, Kite/Gilead and Miltenyi Biotec.) …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1291. Safety of Isavuconazole Compared with Voriconazole as Primary Antifungal Prophylaxis in Allogeneic Hematopoietic Cell Transplant Recipients
  10. 22230
    “…Miguel-Angel Perales, MD, Abbvie (Other Financial or Material Support, Honoraria from Abbvie, Bellicum, Celgene, Bristol-Myers Squibb, Incyte, Merck, Novartis, Nektar Therapeutics, Omeros, and Takeda.)ASTCT (Other Financial or Material Support, Volunteer member of the Board of Directors of American Society for Transplantation and Cellular Therapy (ASTCT), Be The Match (National Marrow Donor Program, NMDP), and the CIBMTR Cellular Immunotherapy Data Resource (CIDR) Committee)Cidara Therapeutics (Advisor or Review Panel member, Other Financial or Material Support, Serve on DSMBs for Cidara Therapeutics, Servier and Medigene, and the scientific advisory boards of MolMed and NexImmune.)Kite/Gilead (Research Grant or Support, Other Financial or Material Support, Received research support for clinical trials from Incyte, Kite/Gilead and Miltenyi Biotec.) …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1104. Risk Factors and Outcomes of Refractory and/or Resistant Cytomegalovirus (CMV) Infection after Allogeneic Hematopoietic Stem Cell Transplantation
  11. 22231
    “…Mielke:Novartis: Honoraria, Other: received via my institution, Speakers Bureau; Celgene/BMS: Honoraria, Other: received via my institution , Speakers Bureau; Bellicum: Honoraria, Other: received via my institution, Speakers Bureau; Kite/Gilead: Honoraria, Other: received via my institution , Speakers Bureau; Miltenyi: Honoraria, Membership on an entity’s Board of Directors or advisory committees, Other: received via my institution , Speakers Bureau; KIADIS Pharma: Honoraria, Other: received via my institution , Speakers Bureau; DNA Prime: Honoraria, Other: received via my institution , Speakers Bureau. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    COVID-19 and Stem Cell Transplantation; Results from the Prospective Survey By the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation (EBMT) and the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH)
  12. 22232
    por Martínez, Pilar, Palanques Pastor, Tomás, Lopez Lorenzo, Jose Luiz, Cornago Navascués, Javier, Rodriguez-Macías, Gabriela, Cano, Isabel, Arnan Sangerman, Montserrat, Vidriales, María-Belén, Algarra, Jesús Lorenzo, Foncillas, Maria Angeles, Herrera Puente, Pilar, Botella, Carmen, Vives, Susana, Figuera Alvarez, Angela, Cuevas Palomares, Laida, Sobas, Marta, Contento-Gonzalo, Alejandro, Cuello, Rebeca, Amutio Diez, María Elena, De Miguel, Maria Dunia, Navas, Begoña, Bergua Burgues, Juan Miguel, Bernal del Castillo, Teresa, Mateos Rodríguez, María Carmen, de Cabo López, Erik, Franco Villegas, Ana Carolina, García-Boyero, Raimundo, Escolano Escobar, Cristian, Seri, Cristina, Cervero, Carlos, Roldán Pérez, Alicia, Hermosin, Maria Lourdes, Cervera, Marta, Olave, María Teresa, Villafuerte Gutierrez, Paola Sandra, De Laiglesia, Almudena, Serrano, Josefina, Najera Irazu, María Josefa, Piñana Sanchez, Jose Luis, Sanz, Miguel Ángel, Martinez-Lopez, Joaquin, Montesinos, Pau
    Publicado 2020
    “…DISCLOSURES: Martinez-Lopez:Janssen-cilag: Consultancy, Honoraria, Membership on an entity's Board of Directors or advisory committees; BMS: Consultancy, Research Funding; Novartis: Consultancy; Janssen: Consultancy, Honoraria; Incyte: Consultancy, Research Funding.…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Impact of Sars-Cov-2 Infection in Acute Myeloid Leukemia Patients: Experience of the Pethema Registry
  13. 22233
    “…Brown:Novartis: Consultancy; Global Blood Therapeutics: Consultancy, Membership on an entity's Board of Directors or advisory committees.…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Critical Telehealth and Healthcare Utilization during COVID-19 in Sickle Cell Disease: CBO Reach in Understanding the Patient Experience
  14. 22234
    “…[Figure: see text] DISCLOSURES: von Drygalski:Biomarin, Bioverativ/Sanofi-Genzyme, Novo Nordisk, Pfizer, Uniqure, Takeda: Consultancy; Hematherix Inc: Membership on an entity’s Board of Directors or advisory committees, Other: Cofounder; superFVa; Joint Activity and Damage Examination (JADE) Ultrasound measurement tool: Patents & Royalties.…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Incidence of Venous Thromboembolic Events in Hospitalized COVID-19 Patients: A Systematic Review
  15. 22235
    “…[Figure: see text] DISCLOSURES: Thornburg:Bluebird Bio: Consultancy; Biomarin: Consultancy, Speakers Bureau; Genentech: Speakers Bureau; NovoNordisk: Research Funding; Sanofi Genzyme: Consultancy, Other: Data Safety Monitoring Board, Research Funding; Spark Therapeutics: Consultancy; Ironwood Pharmaceuticals: Consultancy, Other: Data Safety Monitoring Board; National Hemophilia Foundation: Membership on an entity's Board of Directors or advisory committees, Research Funding; Bayer Pharmaceuticals: Research Funding; American Thrombosis and Hemostasis Network: Research Funding.…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Utilization of Telemedicine for Comprehensive Visits in Patients with Inherited Bleeding Disorders during the COVID-19 Pandemic
  16. 22236
    “…[Figure: see text] DISCLOSURES: Torka:  TG Therapeutics: Membership on an entity's Board of Directors or advisory committees. Griffiths:  Takeda Oncology: Consultancy, Honoraria; Alexion Pharmaceuticals: Consultancy, Research Funding; Abbvie: Consultancy, Honoraria; Novartis: Honoraria; Taiho Oncology: Consultancy, Honoraria; Celgene/Bristol-Myers Squibb: Consultancy, Honoraria, Research Funding; Boston Biomedical: Consultancy; Astex Pharmaceuticals: Honoraria, Research Funding; Genentech: Research Funding; Apellis Pharmaceuticals: Research Funding.…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Determinants of COVID-19 Vaccine Response in Patients with Lymphoma on B Cell Directed Therapy
  17. 22237
    “…[Figure: see text] DISCLOSURES: Sartain:  Alexon Pharamaceuticals: Membership on an entity's Board of Directors or advisory committees.…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Sars-Cov-2 Induced Endotheliopathy and the Impact on Clinical Outcomes in Critically Ill Pediatric Patients
  18. 22238
    “…[Figure: see text] DISCLOSURES: Rigaudeau:  Takeda: Membership on an entity's Board of Directors or advisory committees.…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    A Third Anti-Sars-Cov2 mRNA Dose Does Not Overcome the Pejorative Impact of Anti-CD20 Therapy and/or Low Immunoglobulin Level in CLL/Lymphoma Patients
  19. 22239
    “…[Figure: see text] DISCLOSURES: Soulieres:  BMS: Membership on an entity's Board of Directors or advisory committees; Novartis: Research Funding. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    COVID-19 and Sickle Cell Disease in the Province of Quebec: Morbidity and Mortality Rates Derived from the Provincial Registry
  20. 22240
    “…[Figure: see text] DISCLOSURES: Kordasti:  Alexion: Honoraria; Celgene: Research Funding; Beckman Coulter: Honoraria; Novartis: Honoraria, Membership on an entity's Board of Directors or advisory committees, Research Funding. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Response to BNT162b2 Sars-Cov-2 Vaccine in Recipients of Allogeneic Hematopoietic Stem Cell Transplant
Herramientas de búsqueda: RSS